S. Korfee

447 total citations
15 papers, 326 citations indexed

About

S. Korfee is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, S. Korfee has authored 15 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 1 paper in Surgery. Recurrent topics in S. Korfee's work include Lung Cancer Diagnosis and Treatment (8 papers), Lung Cancer Research Studies (8 papers) and Lung Cancer Treatments and Mutations (8 papers). S. Korfee is often cited by papers focused on Lung Cancer Diagnosis and Treatment (8 papers), Lung Cancer Research Studies (8 papers) and Lung Cancer Treatments and Mutations (8 papers). S. Korfee collaborates with scholars based in Germany, United Kingdom and United States. S. Korfee's co-authors include Wilfried Eberhardt, Christoph Pöttgen, Martin Stuschke, Georgios Stamatis, Peter Langmuir, J. Wang, Roy S. Herbst, Thomas Gauler, Chensheng W. Zhou and Paul Germonpré and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and British Journal of Cancer.

In The Last Decade

S. Korfee

14 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Korfee Germany	9	255	206	81	28	20	15	326
Larry Schlabach United States	8	151 0.6×	185 0.9×	101 1.2×	18 0.6×	10 0.5×	10	300
Dominique Rosine France	7	154 0.6×	149 0.7×	72 0.9×	59 2.1×	9 0.5×	9	311
Dongjun Shin United States	5	307 1.2×	375 1.8×	85 1.0×	25 0.9×	6 0.3×	8	448
Martin Kimmich Germany	9	239 0.9×	140 0.7×	47 0.6×	29 1.0×	5 0.3×	22	295
Wanda Honeycutt United States	9	115 0.5×	270 1.3×	106 1.3×	73 2.6×	15 0.8×	20	363
Michel Richez Belgium	9	326 1.3×	274 1.3×	109 1.3×	27 1.0×	3 0.1×	15	422
Alissa Marr United States	8	193 0.8×	171 0.8×	63 0.8×	23 0.8×	12 0.6×	30	310
J.C. Ruffinelli Spain	9	102 0.4×	180 0.9×	90 1.1×	34 1.2×	6 0.3×	27	271
Tatsuya Yoshida Japan	10	306 1.2×	201 1.0×	46 0.6×	33 1.2×	13 0.7×	19	340
Susan E. Jorge Brazil	7	200 0.8×	137 0.7×	112 1.4×	20 0.7×	41 2.0×	22	303

Countries citing papers authored by S. Korfee

Since Specialization

Citations

This map shows the geographic impact of S. Korfee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Korfee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Korfee more than expected).

Fields of papers citing papers by S. Korfee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Korfee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Korfee. The network helps show where S. Korfee may publish in the future.

Co-authorship network of co-authors of S. Korfee

This figure shows the co-authorship network connecting the top 25 collaborators of S. Korfee. A scholar is included among the top collaborators of S. Korfee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Korfee. S. Korfee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Pöttgen, Christoph, Wilfried Eberhardt, Thomas Gauler, et al.. (2009). Intensified High-Dose Chemoradiotherapy With Induction Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer—Safety and Toxicity Results Within a Prospective Trial. International Journal of Radiation Oncology*Biology*Physics. 76(3). 809–815. 18 indexed citations

Reck, Martin, Rolf A. Stahel, Joachim von Pawel, et al.. (2009). Pemetrexed in the treatment of malignant mesothelioma: Results from an expanded access program in Germany. Respiratory Medicine. 104(1). 142–148. 13 indexed citations

Herbst, Roy S., Yi Sun, S. Korfee, et al.. (2009). Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small cell lung cancer (NSCLC): A randomized, double-blind phase III trial (ZODIAC). Journal of Clinical Oncology. 27(18_suppl). CRA8003–CRA8003. 31 indexed citations

Herbst, Roy S., Yan Sun, S. Korfee, et al.. (2009). Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small cell lung cancer (NSCLC): A randomized, double-blind phase III trial (ZODIAC). Journal of Clinical Oncology. 27(15_suppl). CRA8003–CRA8003. 66 indexed citations

Eberhardt, Wilfried, S. Korfee, Bruce E. Johnson, et al.. (2007). PD3-3-4: Vandetanib in advanced NSCLC: an ongoing clinical evaluation program. Journal of Thoracic Oncology. 2(8). S467–S468. 2 indexed citations

Pöttgen, Christoph, Wilfried Eberhardt, S. Korfee, et al.. (2007). Prophylactic Cranial Irradiation in Operable Stage IIIA Non–Small-Cell Lung Cancer Treated With Neoadjuvant Chemoradiotherapy: Results From a German Multicenter Randomized Trial. Journal of Clinical Oncology. 25(31). 4987–4992. 94 indexed citations

Marra, Alessandro, Wilfried Eberhardt, Christoph Pöttgen, et al.. (2006). Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour. European Respiratory Journal. 29(1). 117–126. 46 indexed citations

Korfee, S., Tokuzo Arao, Thomas Krbek, et al.. (2006). ZD6474 (ZACTIMA™), a novel inhibitor of VEGF receptor-2 tyrosine kinase, inhibits cellular growth of mesothelioma cell lines in vitro. 66. 1115–1116. 1 indexed citations

Gauler, Thomas, Verena Sailer, S. Korfee, et al.. (2005). O-034 Preoperative chemotherapy and concurrent radio-chemotherapyfollowed by definitive surgery (“Trimodality”) in patients with locally advanced inoperable non-small-cell lung cancer stage IIIA/IIIB — 10-year-survival results. Lung Cancer. 49. S14–S14.

10.

Eberhardt, Wilfried, Thomas Gauler, S. Korfee, et al.. (2004). The role of chemoradiotherapy in the treatment of stage III non-small-cell lung cancer. Annals of Oncology. 15. iv71–iv80. 3 indexed citations

11.

Mross, K., Heike Richly, N. Schleucher, et al.. (2004). A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors. Annals of Oncology. 15(8). 1284–1294. 21 indexed citations

12.

Korfee, S., et al.. (2004). New targeted treatments in lung cancer — overview of clinical trials. Lung Cancer. 45. S199–S208. 10 indexed citations

13.

Awada, Ahmad, Jean Klášterský, Christian Stoll, et al.. (2003). Abstracts. British Journal of Cancer. 89(S2). S25–S35. 1 indexed citations

14.

Antoch, Gerald, Thomas Egelhof, S. Korfee, et al.. (2002). Recurrent schwannoma: Diagnosis with PET/CT. Neurology. 59(8). 1240–1240. 8 indexed citations

15.

Eberhardt, Wilfried, Stephan Bildat, & S. Korfee. (2000). Lung cancer: Combined modality therapy in NSCLC. Annals of Oncology. 11. 85–96. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact